Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pain Patch Market, by Distribution Channel
1.4.2 Europe Pain Patch Market, by Type
1.4.3 Europe Pain Patch Market, by Product Type
1.4.4 Europe Pain Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Pain Patch Market by Distribution Channel
3.1 Europe Drug Stores & Retail Pharmacies Market by Country
3.2 Europe Hospital Pharmacies Market by Country
3.3 Europe Online Providers Market by Country
Chapter 4. Europe Pain Patch Market by Type
4.1 Europe Prescription Medicines Market by Country
4.2 Europe OTC Medicines Market by Country
Chapter 5. Europe Pain Patch Market by Product Type
5.1 Europe Non-Opioid Patches Market by Country
5.2 Europe Pain Patch Market by Non-Opioid Patches Type
5.2.1 Europe Nonsteroidal Anti-Inflammatory Drugs Market by Country
5.2.2 Europe Methyl Salicylate Market by Country
5.2.3 Europe Lidocaine Market by Country
5.2.4 Europe Others Market by Country
5.3 Europe Opioid Patches Market by Country
Chapter 6. Europe Pain Patch Market by Country
6.1 Germany Pain Patch Market
6.1.1 Germany Pain Patch Market by Distribution Channel
6.1.2 Germany Pain Patch Market by Type
6.1.3 Germany Pain Patch Market by Product Type
6.1.3.1 Germany Pain Patch Market by Non-Opioid Patches Type
6.2 UK Pain Patch Market
6.2.1 UK Pain Patch Market by Distribution Channel
6.2.2 UK Pain Patch Market by Type
6.2.3 UK Pain Patch Market by Product Type
6.2.3.1 UK Pain Patch Market by Non-Opioid Patches Type
6.3 France Pain Patch Market
6.3.1 France Pain Patch Market by Distribution Channel
6.3.2 France Pain Patch Market by Type
6.3.3 France Pain Patch Market by Product Type
6.3.3.1 France Pain Patch Market by Non-Opioid Patches Type
6.4 Russia Pain Patch Market
6.4.1 Russia Pain Patch Market by Distribution Channel
6.4.2 Russia Pain Patch Market by Type
6.4.3 Russia Pain Patch Market by Product Type
6.4.3.1 Russia Pain Patch Market by Non-Opioid Patches Type
6.5 Spain Pain Patch Market
6.5.1 Spain Pain Patch Market by Distribution Channel
6.5.2 Spain Pain Patch Market by Type
6.5.3 Spain Pain Patch Market by Product Type
6.5.3.1 Spain Pain Patch Market by Non-Opioid Patches Type
6.6 Italy Pain Patch Market
6.6.1 Italy Pain Patch Market by Distribution Channel
6.6.2 Italy Pain Patch Market by Type
6.6.3 Italy Pain Patch Market by Product Type
6.6.3.1 Italy Pain Patch Market by Non-Opioid Patches Type
6.7 Rest of Europe Pain Patch Market
6.7.1 Rest of Europe Pain Patch Market by Distribution Channel
6.7.2 Rest of Europe Pain Patch Market by Type
6.7.3 Rest of Europe Pain Patch Market by Product Type
6.7.3.1 Rest of Europe Pain Patch Market by Non-Opioid Patches Type
Chapter 7. Company Profiles
7.1 NEXGEL, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Viatris, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Grünenthal GmbH
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trials:
7.6 Sorrento Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expenses
7.7 Hisamitsu Pharmaceutical Co. Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Recent strategies and developments:
7.7.3.1 Product Launches and Product Expansions:
7.8 Endo International PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expense
7.9 Purdue Pharma L.P.
7.9.1 Company Overview
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.1 Approvals & Trials:
Unique Offerings 
